Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BHVN Biohaven Pharmaceutical

151.970
+0.210+0.14%
Close 09/26 16:00 ET
151.9700.0000.00%
Post Mkt Price 09/26 16:30 ET
High
152.160
Open
151.630
Turnover
333.62M
Low
151.520
Pre Close
151.760
Volume
2.19M
Market Cap
10.87B
P/E(TTM)
Loss
52wk High
152.160
Shares
71.49M
P/E(Static)
Loss
52wk Low
79.010
Float Cap
9.69B
Bid/Ask %
0.00%
Historical High
152.160
Shs Float
63.73M
Volume Ratio
1.46
Historical Low
16.500
Dividend TTM
--
Div Yield TTM
400
P/B
-13.57
Dividend LFY
--
Div Yield LFY
263.21%
Turnover Ratio
3.44%
Amplitude
0.42%
Avg Price
152.008
Lot Size
1
Float Cap
9.69B
Bid/Ask %
0.00%
Historical High
152.160
Shs Float
63.73M
Volume Ratio
1.46
Historical Low
16.500
Dividend TTM
--
P/B
-13.57
Dividend LFY
--
Turnover Ratio
3.44%
Amplitude
0.42%
Avg Price
152.008
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.
CEO: Mr. Vlad Coric, M.D.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...